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1. Introduction
Many questions have plagued the study of the etiology and subsequent treatment of men‐
tal illness. In part, it is simply because, as far as we know, some mental illnesses are some‐
what  unique  to  the  human  condition.  Moreover,  clinical  studies  have  produced  many
different  results  concerning  potential  biomarkers  for  conditions  such  as  post-traumatic
stress disorder (PTSD) and major depressive disorder (MDD). In this chapter, we review
how we approached modeling a specific behavioral condition, suppression of the startle re‐
flex, by examining whether one of two commonly associated peripheral biomarkers of anxi‐
ety and depression could potentially cause this rather specific symptom. The two peripheral
systems under investigation were the hypothalamic-pituitary-adrenal (HPA) axis and the
peripheral pro-inflammatory immune response, both of which have been implicated as a
vulnerability factor, causal factor, or resultant (perpetuating) effect of PTSD and MDD.
Our general theory is that peripheral endocrine and immune signals, measured to be abnor‐
mal in patients with either PTSD or MDD (as well as other mental disorders), are actually
perpetuating the behavioral features of these disorders. At the same time, if an individual
has an immunosensitivity or has an overactive adrenal gland, s/he would be more likely to
experience some of the symptoms associated with one of the particular mental illnesses. This
may then lead the brain to compensate for those peripheral abnormalities, but, at the same
time, cause other imbalances, which lead to the experience of a decline into mental illness.
Thus, treating these peripheral markers as part of the “mental” disorder may be quite bene‐
ficial in normalizing certain aspects of the diagnosed abnormal behavior.
© 2013 Beck and Catuzzi; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
2. The startle reflex and mental health
2.1. The startle reflex as an assessment tool
One of the major impediments to the mechanistic study of mental illness is establishing ana‐
logs of the abnormal behaviors expressed in humans in animal models, especially in sub-pri‐
mate species. This has led some to adopt reflex-based measures such that the face and
construct validity of the behavior change can be readily translated between the model and
patient populations. Consequently, a popular measures for the study of anxiety disorders
has been the potentiation of the startle reflex; however, there is growing evidence that a
dampening of the startle response may be indicative of changes in physiology that underlie
different mental disorders.
The startle reflex comprises a 3-synaptic sensory-motor neuronal pathway that serves as a
defensive behavioral response to abrupt, usually intense, stimuli. The acoustic startle re‐
sponse (ASR) is the most commonly used form for studying this reflex. As shown in Figure
1, the primary ASR circuit begins with neurons in the cochlear nerve, transmitting the repre‐
sentation of the acoustic stimulus from the cochlea of the inner ear to the cochlear nucleus
(in the brainstem). Efferent pathways from the cochlear nucleus project to the nucleus reticu‐
laris pontis caudalis (PnC), in the pons, forming the second synapse in this reflex arc. The
third synapse forms from the efferent projections from the PnC to various motor nuclei,
through the recticulospinal spinal tracts to the muscles of the torso [1] and the muscles ener‐
vated by the facial nerve. These muscle enervations create a rapid cascade of near-immedi‐
ate behavioral responses to abrupt acoustic stimuli, ranging from less than 10 ms to
approximately 50 ms.
The ASR is modulated by several afferent connections originating from higher brain areas
(midbrain, limbic, and cortical nuclei). At the level of the PnC, there are several inputs that
can either enhance or inhibit the magnitude of an elicited ASR. In the area of fear and anxi‐
ety, the central amygdala and bed nucleus of the stria terminalis (BNST) are considered the
2 major excitatory modulation structures on this reflex [2]. Some have proposed that the
BNST is the origin of anxiety-like behaviors whereas the nuclei of the amygdala are the ori‐
gin of acute fear responses and explicit fear-learning [3, 4]. The amygdala is predominately
associated with causing classically conditioned fear-potentiated ASRs [5], and, in fact, has
been specifically shown not to have a role in startle inhibition, at least via a learned condi‐
tioned inhibitor [6]. On the other hand, the process known as pre-pulse inhibition of the
startle reflex (PPI) has elucidated neural pathways that can inhibit the expression of the
ASR. For instance, the substantial nigra pars retriculata (SNR), pedunculopontine tegmen‐
tum (PPT) and laterodorsal tegmental nuclei (LDT) have inhibitory influence upon the PnC,
thus reducing the measured ASR [7-10]. These three mid-brain nuclei (inhibitory) receive
projections from various forebrain areas, including the amygdala, BNST, and medial pre‐
frontal cortex (mPFC). Thus, limbic system modulation of the ASR can occur through direct
enervation of the PnC (excitatory) or indirect enervation through mid-brain nuclei.
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Figure 1. There are several nuclei within the midbrain/brainstem area that can directly modulate the intrinsic ASR cir‐
cuit at the level of the nucleus reticularis pontis caudalis (PnC). Dashed red lines represent cholinergic inhibitory influ‐
ences from the laterodorsal tegmental nuclei (LDT) and pedunculopontine tegmentum (PPT). Dashed black lines
represent inhibitory GABAergic projections from the substantial nigra pars reticulata (SNR). A solid line from the para‐
brachial nucleus (PBN) is an example of a direct excitatory input to the PnC.
2.2. Abnormalities in the expression of the startle reflex in mental disorders
Over all other mental disorders, PTSD is associated with changes in the startle reflex. Com‐
monly associated with exaggerated startle responses [11-14], higher or exaggerated startle
reflex responses are a criteria symptom for the diagnosis of PTSD [15]. However, recent evi‐
dence suggests that this may not always be the case. In fact, others have reviewed the litera‐
ture and found there are a significant number of reports where the startle responses in PTSD
patients are not exaggerated [16]. More extreme, there are reports, albeit limited, where pa‐
tients diagnosed with PTSD appeared to have blunted motor reflex responses to an acoustic
stimulus [17, 18]. These populations had distinctive qualities that were different than those
studies that had found enhanced startle reactivity in their PTSD patients. First, the one study
was exclusively female [18] and the other had a majority of female subjects [17], suggesting
there may be a sex difference in the presentation of ASR in females as a result of experienc‐
ing trauma. However, others have reported enhanced startle responses in a different popu‐
lation of women diagnosed with PTSD following automobile accidents [19]. Thus, a second
distinction between the two studies that observed suppressed startle reactions, which
should be considered, is that the trauma was specifically associated with being the target of
violence [17, 18]. Although women with a PTSD diagnosis stemming from a prior rape have
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not always exhibited blunted startle responses [20], this discrepancy may be due to individ‐
ual differences and/or methodological differences in being sensitive to such changes, as
some have reported laterality effects in PTSD patients, notably of those having been raped
in the past [21]. A third quality of at least one of these two reports is that the subjects also
exhibited symptoms associated with major depressive disorder [18]. This suggests stressful
experiences may not cause a uniform change in sensory reactivity, and the expression of the
coping response to the trauma may have psychophysiological ramifications that are quite
different, both in terms of effects upon sensory-motor responding to acoustic stimuli as well
as the full expression of symptoms.
There is evidence that symptoms associated with depression may also include a blunted reac‐
tion to acoustic stimuli. Patients designated as “depressed”, having either a diagnosis of MDD
or a significantly higher score on the Beck Depression Inventory (with or without additional
neurological conditions), have been reported to exhibit blunted reactivity to acoustic stimuli,
either with or without manipulations of affect [22-26]. Similarly, there is also evidence that bi‐
polar disorder (BPD), the occurrence of at least one manic or mixed manic episode over the
course of a patient’s lifetime, is characterized by blunted startle reactions as well, even during
periods of remission [27]. A study by Carroll and colleagues found patients suffering from
BPD exhibit attenuated baseline startle, most notably in those having experienced mixed epi‐
sodes, not pure mania [28]. These data suggest there is a neurobiology of startle suppression
that may provide critical insight to the underlying biological conditions that cause areas of the
brain to improperly process information, in this case sensory-motor responses.
2.3. Animal models utilizing stress to dampen startle reactivity
Across the studies that have documented reductions in the expression of the startle reflex in ro‐
dents, the common-most feature is that the magnitude of the response is dampened following
exposure to a stressor manipulation. Reduced startle amplitudes have been documented in
rats following: repeated 20 min restraint [29]; inescapable tailshock [30-32]; predator exposure
coupled with an intraperitoneal injection [33]; immune-challenge [34, 35], and a single session
of footshocks [36]. Interestingly, despite some differences in methodology, inescapable tail‐
shock [30], inescapable footshock [36], and predator exposure with injection [33], all showed
reduction in ASR measurements that could not be attributable to enhanced habituation to the
acoustic stimuli. Yet, studies utilizing inescapable tailshock (in females) have established that
exposure to the stressor condition causes a change in startle responsivity (the magnitude of the
measured startle responses), not startle sensitivity (the threshold to elicit a certain percentage
of startle responses). Thresholds for eliciting ASRs are not increased in the shocked females; in‐
stead, the magnitudes of the elicited startle responses are lower [31, 32]. This suggests, at least
for the female stress model, that the presumed increased inhibition upon the activity in the in‐
trinsic ASR circuit is occurring through the motor response aspect of the reflex arc. The mus‐
cles are simply not as mobilized when this condition is induced. This model condition has been
termed by some stress-induced startle suppression [32, 34].
There are significant differences in the temporal characteristics of these different startle-sup‐
pression models in rodents. Inescapable tailshock causes a reduction in startle magnitude in
female rats that is evident hours within exposure [31, 32], possibly lasting up to a day later,
when the bouts of shock are expanded to a few consecutive days [30]. The footshock-in‐
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duced suppression of startle reactivity is evident 4 h following stressor exposure [36]. The
immune-challenge models parallel these stressor manipulations by causing reductions in
startle reactivity within a couple hours of administration of the challenge [34, 35]. Thus, one
interpretation of these data is that painful stressors are causing changes in the peripheral im‐
mune system, which, in turn, dampen startle reactivity during the time of their activity [34],
on the range of hours. Following this logic, when females were tracked 4 and 8 days follow‐
ing tailshock, reductions in startle reactivity in the stressor-exposed rats did not reach statis‐
tical significance [30]. In contrast, the predator-exposure + injection model shows immediate
suppression following the stressor exposure, which continues to be present 1 week later [33].
In addition, it is evident both under dark and light conditions [33], suggesting the change in
the startle response is not occurring due to a change in reactivity to other stimuli that are
known to modulate startle reactivity, such as light-enhanced startle [37]. Thus, this observ‐
ance suggests that changes in ASR magnitude may be extended beyond the acute effects of
stressor exposure that could be attributed to the short-term effects of immune signaling that
would be in response to the injection (or possibly even shock).
3. Peripheral mechanisms of reduced startle reactivity
3.1. Hypothalamic-Pituitary Adrenal (HPA)–axis
Two interrelated mechanisms have been proposed as potential causes of startle suppression,
the first being glucocorticoid hormone reception. Adamec and colleagues showed the reduc‐
tion of startle magnitudes following combined cat exposure and saline injection could be
blocked by substituting the saline injection with the glucocorticoid receptor antagonists
RU-486 [33]. We subsequently tried to induce the effect in our female rats by administering
the synthetic glucocorticoid agonist, dexamethasone. Startle responses were assessed 2 and
4 h following dexamethasone administration. As shown in Figure 2, the dexamethasone did
not appreciably change the magnitude of the elicited ASRs, nor did it affect the number of
ASRs elicited (data not shown). These findings suggest that the reception of corticosterone at
the glucorticoid receptor is not sufficient to reduce ASR magnitudes. One possibility is that
RU-486 blocked the suppressed startle, in that model system, via a non-glucocorticoid mech‐
anism, for example via progesterone receptor antagonism. A connection to progesterone
will be discussed further below as it pertains to a pro-inflammatory response mechanism, in
contrast to an anti-inflammatory glucocorticoid response, but this finding is supported by
previous work that shows elevations in circulating corticosterone are not necessary for corti‐
cotrophin releasing hormone to increase ASR magnitudes, despite stimulating increased ac‐
tivity in the HPA-axis [38]. Likewise, the suppression of ASR magnitudes in Occidental low
saccharine consuming rats is not recapitulated by substituting corticosterone administration
for the shock exposure [36]. Therefore, a role of glucocorticoids in the suppression of ASR
magnitudes may be limited.
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Figure 2. In order to increase binding at the glucocorticoid receptors, the synthetic glucocorticoid analog, dexametha‐
sone, was administered s.c. (0.1 mg/kg) to female Sprague Dawley rats (n= 8-9). The magnitudes of the elicited ASRs
only differed across the Stimulus Intensity, F (1, 15) = 135.3, p <.001, not drug administration. Data are collapsed over
the 2 startle test sessions. A cross (†) represents within-group difference from the highest stimulus intensity (p <.05,
Fishers LSD).
3.2. Pro-inflammatory cytokines
The second mechanism, which is intertwined with the HPA-axis, is the peripheral pro-in‐
flammatory immune response. We first showed that a ovarian hormone-dependent suppres‐
sion of startle magnitudes could be induced by a single injection of the pro-inflammatory
cytokine interleukin (IL)-1β [34], an effect that appears to parallel that observed following
tailshock [31]. This effect was later replicated in male rats using lipopolysaccharide (LPS)
[35]. Still, peripherally released IL-1β elicits the release of glucocorticoids from the adrenal
through stimulation of the vagus nerve, paraventricular nucleus of the hypothalamus, and
pituitary gland, which provides an anti-inflammatory response to the pro-inflammatory sig‐
nal [39-44]. In order to further delineate that pro-inflammatory cytokines, and not anti-in‐
flammatory glucocorticoids, are necessary for stress-induced startle suppression, we
compared the effect of inescapable tailshock upon the induction of ASRs in two strains of
rats, specifically chosen because of their pro-inflammatory and glucocorticoid responsive‐
ness to stressors. Low-glucocorticoid/high-pro-inflammatory releasing Lewis (LEW) rats
[45-49] and high-glucocorticoid releasing Wistar-Kyoto (WKY) rats [50-52] were compared.
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Females of each of these strains were exposed to inescapable tailshock and subsequently
tested for startle reactivity 1 and 3 h later. If pro-inflammatory signaling, not anti-inflamma‐
tory glucocorticoid release is critical for eliciting startle suppression, then LEW rats would
exhibit suppression of the ASR, and the WKY rats would not. As shown in Figure 3, this is
the case. This suggest the suppression of startle responsivity in female rats is more likely
due to an overactive pro-inflammatory cytokine signaling response, instead of an overactive
anti-inflammatory glucocorticoid response via the HPA-axis.
Figure 3. LEW rats exposed to the stressor differed from both their same-strain controls and the WKY groups on the
measure of startle magnitude (responsivity). These impressions were confirmed by both main effects of Stimulus In‐
tensity, F (1, 36) = 285.0, p <.0001, Strain, F (1, 36) = 6.4, p <.02, and Stressor exposure, F (1, 36) = 5.3, p <.03, as well as
a marginal Strain x Stressor interaction, F (1, 36) = 3.3, p <.07. In addition to the expected differences in ASR magni‐
tude due to Stimulus Intensity, F (2, 72) = 186.5, p <.0001, there were differences in the number of elicited startles
across the two strains at the lowest stimulus intensity, with WKY rats having responded with more startles (4.5) than
did the LEW rats (3.8) to 92 dBA stimulus. This impression was confirmed by a significant Strain x Stimulus Intensity
interaction, F (2, 72) = 3.0, p <.05 (data not shown).
The hypothesis that pro-inflammatory cytokines are a necessary component in the suppres‐
sion of startle responses following stress was further evaluated in the immune-sensitive Lewis
rat strain by determining if elevations of peripheral IL-1β is sufficient to suppress startle reac‐
tivity in female rats. Startle responsivity has been found to be suppressed in female SD rats
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[34], but, we questioned whether immune-sensitive Lewis rats would show either greater ef‐
fect sizes in the suppression of the startle magnitudes and/or reduced startle sensitivity as well.
As shown in Figure 4, both startle responsivity and sensitivity were reduced in female Lewis
rats administered IL-1β. This confirms that pro-inflammatory signaling can influence both as‐
pects of startle behavior, with sensitivity effects requiring a greater sensitivity to the pro-in‐
flammatory signals or, possibly, greater elevations of the signal.
3.3. Prior immune challenge effects on stress-induced startle in SD rats
One consequence of the peripheral immune system having an effect on behavior, in this case
sensory reactivity to acoustic stimuli, is that prior immune challenges may influence how fu‐
ture pro-inflammatory signaling or anti-inflammatory glucocorticoid responses influences
behavior following stressor exposure. LPS is a commonly used endotoxin that elicits sick‐
ness behaviors due to a release of peripheral and central pro-inflammatory cytokines, fol‐
lowed by an increase in circulating glucocorticoids [53, 54]. Others have shown that immune
challenges days prior to shock exposure causes a greater increase in glucocorticoid release in
response to shocks [55, 56]; therefore, we used this known method of causing a sensitized
glucocorticoid response to determine if a greater glucocorticoid release enhances or reduces
the degree by which tailshock suppresses startle responsivity.
Figure 4. Female LEW rats (n = 16) exhibited significant differences in both startle sensitivity and startle responsivity
measures following a single systemic injection of IL-1β (3 μg/kg, i.p.). Startle sensitivity was equally effected 1 and 3 h
following administration and is shown collapsed over Session Time. Startle responsivity was only effected 1 h follow‐
ing administration; therefore, the 3 h time-point is not shown. An asterisk (*) represents a significant difference from
saline-treated controls at the same stimulus intensity. A cross (†) represents a significant difference from saline-treated
controls during the same test session (all p <.05, Fishers LSD).
We hypothesized that pro-inflammatory signaling causes stress-induced startle suppression;
therefore, experiencing an immune challenge 3 days prior to shock would cause a sensitized
anti-inflammatory release of glucocorticoids in response to inescapable shock, blocking the
reduction of startle responsivity caused by the acute release of pro-inflammatory cytokines.
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As expected, the number of startle responses elicited did not differ based on prior treatment
but did differ across stimulus intensity (data not shown); however, prior exposure to LPS
reduced the effectiveness of inescapable shock to attenuate startle magnitudes (see Figure 5).
Although LPS has a short-term suppressing effect upon the startle response [35], it both
causes an acute increase in pro-inflammatory cytokines (and sickness behaviors) followed
by an increase in anti-inflammatory glucocorticoid signaling. This “priming” effect upon the
anti-inflammatory glucocorticoid response to shock is a likely mechanism for “buffering”
the behavior from being affected. Again, this suggests the glucocorticoid response may ac‐
tually counteract the suppressive effects originating from peripheral pro-inflammatory cyto‐
kine signaling.
Figure 5. The expression of stress-induced startle suppression became evident 3 h following stressor exposure; how‐
ever, this effect was blocked in those rats previously exposed to 30 µg/kg LPS (i.p.) 3 days earlier. These impressions
were confirmed by a significant LPS x Stress x Session interaction, F (1, 28) = 10.2, p <.005. Hence, the pretreatment
with LPS, which should have increased the glucocorticoid response to the inescapable tailshocks, blocked the suppres‐
sion of startle responsivity following shock exposure. This suggests that prior experiences likely cause a more robust
anti-inflammatory glucocorticoid response that actually reduces the influence of the peripheral immune pro-inflam‐
matory immune response upon the areas of the brain capable of suppressing startle responsivity.
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4. Central mechanisms of reduced startle reactivity
4.1. Neuroanatomy and endocrine modulation of startle suppression
As mentioned above, studies of pre-pulse inhibition of the ASR have elucidated neural cir‐
cuitry that underlie the suppression of ASRs when they are immediately preceded by a sali‐
ent auditory stimulus, for a review see [57]. Both the BNST and AMG have indirect
projections to the PnC through the PPT [58]. Inputs from the PPT, LDT, and SNR to the PnC
cause inhibition of the startle response [7, 9, 59, 60]. More specifically, it appears the magno‐
cellular portion of the PnC has muscarinic receptors to receive the inhibitory cholinergic sig‐
nal from PPT and LDT [61] and GABAB receptors receive the inhibitory signal from the SNR
[62]. The question is whether these areas could provide more tonic inhibition of the ASR,
outside of the attentional processes associated with PPI. For instance, it is known that le‐
sions to the medial septum and the fimbra-fornix increase startle reactivity because these
areas provide tonic inhibition upon the amygdala [63]; thus, removal of inhibition upon the
amygdala increases tonic excitatory activity to the PnC (from the amygdala). In contrast, le‐
sions to the noradrenergic cell bodies of the LC reduce startle response magnitudes, as these
neurons probably serve a tonic excitation function upon the PnC [64]. Thus, there are cir‐
cuits within the brain that are situated such that they could provide more tonic changes in
the ASR.
Specific to the female startle-suppression model, a central mechanism that caused this
change in reactivity should be influenced by the presence/absence of ovarian hormones [31,
32]. Ovarian hormones can have a significant impact on many of the neural structures asso‐
ciated with startle regulation. The cochlear nuclei [65], the nucleus accumbens [66], the hip‐
pocampus, [67] and the SNR [57] all exhibit changes in morphology, neurotransmission,
and/or receptor expression with the presence of ovarian hormones. Yet, despite all these
areas of influence, rodent studies usually do not find any differences in baseline startle reac‐
tivity across the estrus cycle or with hormone replacement [68, 69]; however, see [70] for an
example of oral-contraceptive usage effecting baseline startle in women. When significant
arousal or stress occurs in the rodents, however, the modulatory actions of ovarian hor‐
mones on startle become evident. For example, Toufexis and colleagues have shown the
magnitude of CRH-enhanced startle is attenuated when progesterone levels are increased
[71]. CRH is thought to enhance startle reactivity in the BNST via CRF1-type receptors
[72-75]. The result is an increase in excitatory afferents signaling to the PnC [76]. One possi‐
bility is that progesterone, or its metabolite allopregnanolone, may decrease the excitatory
signaling from the BNST to the PnC by increasing GABA inhibition in this structure [77].
However, in vitro, BNST CRF-1 receptors increase local GABA activity [78]. Thus, it appears
that progesterone or allopregnanolone should facilitate the actions of CRH on startle, unless
they act through different mechanisms within the BNST or outside of the BNST. On the oth‐
er hand, progesterone also affects how IL-1β influences sexual receptivity [79], and both glu‐
cocorticoid receptor activation [77] and progesterone-induced changes in central
neuroadrenergic activity [80] have been suggested to attenuate startle reactivity selectively
in female rats. As shown in Figure 6, the administration of progesterone to ovariectomized
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rats appears to be necessary for IL-1β to suppress startle magnitudes. Thus, ovarian hor‐
mones are not sufficient to cause changes in startle reactivity in female rats. In fact, IL-1β
appears to increase startle responsivity following estradiol pretreatment (17β-estradiol),
whereas progesterone pretreatment sets the stage for IL-1β to suppress startle responsivity.
Therefore, stress-induced startle suppression in female rats appears to necessitate a combi‐
nation of the two factors, a peripheral pro-inflammatory immune response and the presence
of progesterone.
Figure 6. Startle sensitivity and responsiveness were assessed 2 h following IL-1β administration. Hormone treatment
occurred 2 h prior to IL-1β injection. Differences in startles elicited (sensitivity) and the magnitudes of those elicited
startle responses (responsivity) each were assessed via a 5 (Condition) x 3 (Stimulus Intensity) repeated measures AN‐
OVA. No significant differences in startle sensitivity were detected (data not shown). However, a significant main ef‐
fect of Stimulus Intensity, F (2, 70) = 392.2, p <.001 and a significant Condition x Stimulus Intensity interaction, F [8, 70]
= 2.1, p <.05 were detected in the measure of startle responsivity (magnitude). An asterisk (*) represents a significant
difference from all other groups. A single cross (†) represents a significant difference from the low estradiol dose
group. A double cross (‡) represents a significant difference from both estradiol-treatment groups. All post-hoc tests
used Fishers LSD (p <.05).
4.2. Evidence for limbic regulation of startle suppression
Peripheral IL-1β is known to have a significant impact on brain activity. Systemic IL-1 ad‐
ministration activates key afferent pathways in brainstem (lateral parabrachial nucleus and
dorsomedial and ventrolateral medulla) and limbic system nuclei (BNST and central nu‐
cleus of the amygdala) [81]. In fact, peripheral IL-1β activates the amygdala and BNST more
than i.c.v. administered IL-1β [82], probably because the vagal-mediated signals to these nu‐
clei are more direct, to those nuclei via the NTS, than the diffusion of the IL-1β from the ven‐
tricles. Still, increasing peripheral IL-1β signaling increases NE and serotonin levels in these
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brain areas [83] and noradrenergic metabolism in the paraventricular nucleus of the hypo‐
thalamus (PVN), locus coeruleus (LC), and amygdala [83]. In fact, as the IL-1β dose is in‐
creased, the amount of NE metabolism increases linearly in the amygdala, lasting as much
as an hour [83]. It should be noted, this was not tested in the BNST. Yet, stimulation of α-
adrenergic receptors also attenuate startle responses and facilitate non-associative habitua‐
tion of the startle response [84-88]. IL-1β affects activity in the LC in a dose dependent
manner as well, with low doses inhibiting activity and higher doses causing excitation; a
process mediated by CRH at the time of IL-1β release [89]. Further, when the exposure to
painful stimuli is prolonged or LPS is used to cause a significant pro-inflammatory re‐
sponse, additional release of central IL-1β occurs, especially in the hypothalamus [90, 91].
These data suggest that activity in the limbic system, monoamine activity in particular, is
significantly affected by peripheral immune signaling.
Figure 7. Significant effects of IL-1 treatment on NE levels in the BNST were observed in rats pretreated with proges‐
terone (100 μg/kg, s.c.). This was confirmed by a significant Hormone x IL-1 interaction F (2, 42) = 4.5, p <.02. IL-1β
treatment to oil-treated controls was associated with significantly lower NE levels than oil-treated saline-controls (*).
IL-1β-administered rats, which were pretreated with either estradiol [20 μg/kg, s.c.) or progesterone, exhibited higher
levels of NE compared to oil-pretreated rats that subsequently received IL-1β (†). In addition, the 2 hormone treated
saline control conditions also differed from each other, with the estradiol-treated saline-controls exhibiting higher lev‐
els of NE than those pretreated with progesterone prior to saline administration (‡). All post-hoc tests utilized Fisher’s
LSD (p <.05).
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Based on the above logic, we hypothesized that the reduction in ASR magnitude occurring
as a result of IL-1β administration to progesterone-pretreated female rats could be associat‐
ed with changes in the central noradrenergic activity in one of the known modulatory nuclei
of the acoustic startle response. Therefore, we measured norepinephrine levels in brain tis‐
sue-punches from 4 brain areas: BNST, amygdala, medial prefrontal cortex (mPFC), and
dorsal hippocampus. As stated above, both the BNST and cAMG have direct excitatory pro‐
jections to the PnC and indirect inhibitory connections via the PPT. The medial prefrontal
cortex projects to the primary startle circuit via the LDT, whereas the dorsal hippocampus
was included as an area that is both reactive to stress and ovarian hormone manipulation,
but it is actually several synapses removed from the PPT. As shown in Figure 7, differences
due to hormone pretreatment and subsequent IL-1β administration were found in the BNST,
not in any of the other 3 areas.
Figure 8. Beyond the direct connections of the brainstem/midbrain nuclei, there are many other nuclei that indirectly
influence the modulation of the ASR. Graphically represented here are the noradrenergic projections (in blue) from
the nucleus of the solitary tract (NTS) and locus coeruleus (LC) to the various nuclei of the limbic system that then
modulate the ASR via the inhibitory brainstem/midbrain nuclei. Input to the NTS via either the from the vagus nerve
(X n.) or diffusion of IL-1β across the blood-brain barrier in the nearby area postrema is necessary for the noradrener‐
gic changes in the brain in response to peripheral pro-inflammatory cytokine signaling. As above, red lines denote
cholinergic pathways, and dashed lines represent inhibitory circuits. The orange represents CRH-mediated neural cir‐
cuits. See text for further details.
The role of the BNST in this cytokine-induced change in behavior is logical given recent
work associating activity in this structure with changes in behavior associated with behavio‐
ral depression or sickness behavior. For example, an endotoxin-induced suppression of so‐
cial interactions is both associated with increased activity in the BNST as well as reduced
activity in the BNST when the suppressed behavior is blocked by IL-1ra [92]. Similarly, the
behavioral depression exhibited in the forced-swim test can be reduced by stimulating the
vagus nerve, leading to changes in brainstem nuclei activation (including the NTS) and also
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activation of the BNST [93]. Others have shown NE release is elevated with stressor expo‐
sure in the BNST, which is necessary for some stress-induced behaviors [94, 95]. With partic‐
ular attention to the startle reflex, the BNST is commonly associated with enhancing startle
reactivity [2, 96]. However, as shown in Figure 8), there is an inhibitory pathway from the
BNST to the PnC via the PPT that has been examined as a cholinergic mechanism for elicit‐
ing PPI [97, 98]. Further, PPI has been shown to fluctuate over the estrus cycle, while not
being sensitive to apomorphine disruption, implicating a non-dopaminergic mechanism for
these hormone-induced changes in female pre-pulse inhibition, which could rule-out a role
of the substantia nigra in this process [68]. In addition, the changes in measured NE levels in
the BNST are consistent with previous studies citing peripheral IL-1β administration as a
trigger for central noradrenergic activity [82, 99].
There is evidence that could suggest a connection between the known effects of peripheral cy‐
tokine activity upon brain noradrenergic activity (most reported males) and an ovarian hor‐
mone influence upon these processes. For one, there is growing information pertaining to
ovarian hormone influences on noradrenergic activity initiated from the NTS. Many of the
brainstem noradrenergic nuclei, including the NTS, exhibit cyclic changes in estrogen and pro‐
gesterone receptors [100]. Removal of ovarian hormones with or without hormone replace‐
ment particularly has a significant impact on NTS physiology. Specifically, the mRNA for
prolactin-releasing peptide (PrRP) in noradrenergic neurons is decreased by ovariectomy and
increased with subsequent replacement of either estradiol or progesterone [101]. Although the
PrRP mRNA levels are reported to not change significantly across the estrus cycle in the NTS,
an inspection of the data suggests the levels are a bit higher during proestrus [102]. PrRP label‐
ing in the NTS is also preferentially sensitive to painful stressors, such as tailshock [103]. Estra‐
diol has also been reported to increase neural inhibition in the NTS [104]. These data suggest
ovarian hormone influences on NE NTS physiology could occur through changes in the regu‐
lation of a co-expressing neuropeptide. This could serve a filtering function for the vagal activ‐
ity representing immune activity changes in the periphery, as the NTS projects its NE efferent
connections to key areas involved in arousal and sensory reactivity, such as the BNST, AMG,
hypothalamus, and parabrachial nucleus [105]. For example, core body temperature increases
from peripheral IL-1β occur for a longer period of time during proestrus (compared to dies‐
trus) apparently do to the actions of progesterone [106]. Although it is clear hypothalamic cy‐
clooxygenase is the necessary mechanism for this effect [107] the noradrenergic input to the
hypothalamus is required and may be changed as well [108]. Therefore, there are anatomical
and pharmacological reasons to link NTS noradrenergic projections to the BNST as the pri‐
mary pathway by which changes in vagal activity could influence startle responsivity through
known inhibitory circuitry.
Other possible mechanism for startle suppression could occur as a cascade of effects that begin
with the hormone-specific effects upon NE in the brain, but end with non-specific hormonal in‐
fluences upon 5-HT. NE was shown above to be changed in the BNST following systemic in‐
creases in IL-1β, confirming the results of others showing noradrenergic activity increases
within 30 minutes of a peripheral injection of IL-1β and may last 2 hours [109, 110]. Important‐
ly, as proposed above, the effect of systemic IL-1β injections on brain NE in rodents is depend‐
ent upon transmission in the vagus nerve [111]. The effects of peripheral IL-1β on 5-HT are
quite different in terms of timing, route, and influence of ovarian hormones. First the increases
observed in brain serotonin metabolism are evident 2-4 h following IL-1β administration and,
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at least in male rats, are reported to be less region specific (compared to NE activity changes)
[110]. In addition, the effects of peripheral IL-1β on brain 5-HT are not dependent upon the va‐
gus nerve in male mice but neither are the effects upon brain NE activity [112]. Thus, it is not
known if 5-HT requires the same pathway as IL-1β to effect central 5-HT activity, but the differ‐
ence in the temporal cascade would suggest such a difference is logical. Further, as shown in
Figure 9, the same peripheral IL-1β injections that elicited a hormone-dependent change in
BNST NE levels caused an increase in 5-HT activity in both estradiol and progesterone-treated
female rats. This somewhat conforms to the data previously describing less specificity in the
upregulation of 5-HT activity, although we did not observe this pattern beyond the BNST.
Figure 9. Serotonin activity (5HIAA/5HT ratio) appears to be increased in the BNST of hormone-pretreated OVX fe‐
male rats 2 h after a systemic injection of IL-1β, as suggested by a marginal effect of IL-1β, F (1, 42) = 3.6, p <.06.
5. Immune mechanisms following the acute pro-inflammatory response:
Recovery or maintenance?
5.1. Recovery of startle responsivity
The peripheral immune system also has counter-inflammation mechanisms that could also
be potential mechanisms for what appears to be a pro-inflammatory cytokine-mediated ef‐
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fect. Thus, another response to pro-inflammatory cytokine release, is the increase in the en‐
dogenous IL-1 receptor antagonist (IL-1ra), which has been shown to attenuate the
reductions in food-intake elicited by systemic administration of LPS or IL-1β [113]. Our hy‐
pothesis was that elevations in IL-1ra, from systemic administration, would counteract the
effects of IL-1β. Thus, IL-1ra was administered systemically, followed by an assessment of
startle reactivity 1 and 3 h later. As shown in Figure 10, the peripheral immune mechanism
for stifling the pro-inflammatory response of IL-1β is sufficient to increase startle sensitivity.
This suggests the nervous system is responsive to elevated acute pro-inflammatory signal‐
ing, suppressing startle, and elevations in the counter-active IL-1ra, increasing sensitivity to
acoustic stimuli. These interactions illustrate the constant inter-relationship between the pe‐
ripheral immune system and the nervous system regulation of sensory-motor activity.
Figure 10. Startle magnitudes in female SD rats (n = 7) were not affected by the administration of IL-1ra (10μg/kg);
however, ASRs were elicited more often following the administration of IL-1ra. These impressions were confirmed by a
significant main effect of Drug F (1, 12) = 9.7, p <.01. The higher sensitivity to the stimuli was superimposed upon the
general difference in elicited startles across the three intensities, as reflected by a main effect of Stimulus Intensity, F
(2, 24) = 67.4, p <.0001. An asterisk (*) represents a significant between-group difference from the vehicle-treated
controls at the same intensity. A cross (†) represents a significant within-subject difference from the lowest intensity,
and a double cross (‡) represents a significant within-subject difference from the highest intensity (all p <.05, Fishers
LSD).
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5.2. Immune influences on serotonin synthesis: A possible central mechanism of
continued suppression?
Serotonin (5-HT) is an essential modulator of the startle reflex and disruption of serotonin
synthesis and metabolism has been shown to result in startle suppression. As shown in Fig‐
ure 11, during the synthesis of serotonin, L-tryptophan is converted to 5-hydroxytryptophan
(5-HTP) by the enzyme tryptophan hydroxylase. In a subsequent reaction, 5-HTP is convert‐
ed to 5-HT by the enzyme L-aromatic amino acid decarboxylase. Disruption to any part of
the 5-HT synthesis pathway is capable of reducing whole brain levels of serotonin resulting
in unique abnormalities to the startle reflex. For example, when normal fasted women were
tested after having ingested a tryptophan-free amino-acid mixture, the result was lower ASR
magnitudes compared to those that received a mixture with L-tryptophan in its contents
[114]. When a similar study was conducted in men, a non-significant trend for the same ef‐
fect appears evident, although it was represented in the analysis as a failure to obtain signifi‐
cant PPI [115]. Alternatively, increasing tryptophan catabolism has also shown to affect PPI.
Increasing levels of kynurenine, the first product of tryptophan degradation via indolea‐
mine2, 3-dioxygenase, disrupts PPI in male Sprague-Dawley Rats [116]. Thus, the balance of
serotonin and kynurenine is a likely secondary mechanism the body uses to modulate startle
sensitivity and responsivity to stimuli.
Figure 11. The normal synthesis of serotonin (5-HT) involves the metabolism of tryptophan to 5-hydroxytryophan by
tryptophan hydroxylase; however, in the presence of interferon-γ, another, competing enzyme, indolamine1,3-dioxy‐
genase is upregulated. The result of this shift in the metabolism of tryptophan towards the formation of kynurenine is
a reduction in the amount available for metabolism towards the formation of serotonin (i.e. serotonin depletion).
In addition to exhibiting reduced startle responses [18] women exhibiting PTSD, linked to
previous intimate partner violence, also exhibit greater circulating levels of interferon (INF)-
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γ [117]. INF-γ is a downstream Th-1 mediated signal from the pro-inflammatory IL-1β sig‐
nal and is a potent inhibitor of 5-HT synthesis, decreasing the amount of tryptophan
available for 5-HT production. In the presence of IFN-γ, tryptophan is shunted to kynurenic
acid synthesis by increasing activity of indoleamine2, 3-dioxygenase [118]. An intermediary
signal between IL-1β and INF-γ is IL-2. Female rats treated with IL-1ra (to combat the induc‐
tion of EAE) exhibit an attenuated IL-2 response [119], which would, presumably, decrease
INF-γ signaling (see Figure 12). There is limited experimental evidence that has focused
upon delineating INF-γ or IL-2 effects on startle reactivity in rats, and those that have been
conducted use an early development administration paradigm to assess later changes on be‐
havior (e.g. [120]). However, one study conducted in mice did access acute IL-2 effects upon
startle reactivity and reported no change in behavior [121]. Unfortunately, that study did not
test more than one time-point and only utilized male mice.
Figure 12. The initiation of an inflammatory response begins with the non-specific macrophage pro-inflammatory re‐
sponse (Th0), which then diverges into either a Th1 (cell-based) or Th2 (humoral-mediated) response. There is evi‐
dence that suggests ovarian hormones may influence the path of the subsequent immune cascade from the Th0
response. To date, the Th1 response has been more intently studied for its possible role in effecting behavior (i.e. caus‐
ing changes in behavior).
New Insights into Anxiety Disorders152
Given the lack of data pertaining to IFN-γ effects upon startle sensitivity and responsivity,
we conducted a study focusing on determining whether IFN-γ could change ASR sensitivity
or responsivity. As stated above, LEW rats exhibit greater pro-inflammatory responses to in‐
fection than do other strains; therefore, we tested whether acute administration of IFN-γ is
sufficient to reduce startle reactivity, presumably from reducing serotonin availability. Al‐
though still preliminary, our results suggest IFN-γ may have a bi-potential effect on startle
sensitivity. The higher dose of IFN-γ caused an apparent decrease in the percentage of star‐
tles elicited 1.5 h following injection, whereas the lower dose caused significantly more star‐
tles to be elicited than the high dose (see Figure 13). This is an important distinction, for it
suggests that reduced startle responding due to IFN-γ (and possibly low serotonin tone) is
due to a decrease in the ability to sense a startling stimulus, rather than the ability to mount
the physical response (although there are trends suggesting that responsivity may be de‐
creased as well with higher doses). Hence, there may be more than a hypothetical link be‐
tween stress, IL-1 release, and an identified difference in basal immune functioning in a
population of women with PTSD that have also been described to have blunted startle re‐
sponses. There may be instances where the downstream Th1-response is elevated, thus caus‐
ing a seemingly similar “blunting” of the ASR but the suppression is different in form and
occurs through different neural pathways.
6. Clinical applications
The suppression of startle reactions has only gained significant attention in the past decade,
and, as researchers have looked for changes in startle responses (not just exaggerations), sup‐
pression has been observed in anxiety disorders (i.e. PTSD), MDD, and BPD. However, what
does it mean when a specific, directional change in a reflex behavior is observed across these
different diagnoses? The answer may lie in what is generally called comorbidity.
When one considers stress-related mental disorders, typically, anxiety disorders, MDD,
BPD, and maybe even schizophrenia are cited as examples, but how distinct are anxiety dis‐
orders from MDD or MDD from BPD? In all cases, there is an overlap of various symptoms
that could be experienced with any of these diagnoses. The DSM clinical criteria do provide
some flexibility in categorizing subjects into the different classes of disorders. What that al‐
lows for are physiological conditions that are not specific to just one of these classes, and
chronic or phasic abnormalities in the activities of the peripheral immune system could be
common in some patients that meet the criteria for PTSD, the non-mania phase of BPD, or
even MDD.
For example, there is a growing body of literature that suggests abnormal immune system
signaling may be at the core of BPD. Several studies have shown abnormalities in the cyto‐
kine profiles of BPD patients, with differences present in both depressed and manic subpo‐
pulations [122-124]. Multiple studies have shown a characteristic increase in TNF-α among
both bipolar depressed and manic patients [122, 123], whereas patients suffering from bipo‐
lar mania commonly exhibit decrease in IL-1β, IL-2, and IFN-γ. When stimulated with LPS,
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a common procedure used to model behavioral depression in animals, the monocytes from
non-lithium treated patients exhibit a decrease in the production of IL-1β and an increase in
IL-6, compared to healthy controls. This abnormality was shown to be reversed in lithium
treatment patients [125]. This suggests a by-product of lithium administration may be an in‐
fluence on the pro-inflammatory response signals in the periphery. Additionally, Boufidou
and colleges found that lithium is capable of down regulating the production of IL-2, IL-6,
IL-10 and IFN-γ from peripheral blood lymphocytes in BPD patients, and a similar down
regulation of pro-inflammatory cytokines was observed in previously non-medicated BDP
after three months of lithium treatment [126]. These data further implicate a peripheral im‐
mune mechanism for BPD that is normalized by lithium treatment.
Figure 13. Startle sensitivity and responsivity were assessed 30 and 90 min following an acute systemic injection of
IFN-γ (n = 16). Startle sensitivity was significantly altered by the specific dose administered. The low dose showed an
increase in elicited startles over time, whereas the high dose showed a reduction in elicited startles over time, IFNγ x
Session F (2, 29)= 3.3, p <.05. An asterisk represents a significant difference in the low-dose group at the 90 min test as
compared to the same time high-dose and the 30-min low-dose test.
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Figure 14. Based on the literature and the collected data from our laboratory, concerning the modulation of the ASR,
we propose the following cascade of events may occur as a result of stressor exposure in our female rat model. First,
the acute-phase (pro-inflammatory) response causes a transient reduction in startle responsivity (magnitude) that ap‐
pears to last as long as IL-1 continues to be elevated above the levels of circulating IL-1ra. IL-1ra serves to normalize
the response; thus, when the levels of IL-1ra are elevated to a sufficient degree, it causes an increase in ASR sensitivity
(a rebound effect). However, in the cases where the stressor exposure is prolonged and/or severe enough to engage a
downstream Th-1 response (i.e. increase IFN-γ signaling), then a reduction in ASR sensitivity occurs, whereby the sen‐
sory threshold for eliciting the response is increased. This could cause a chronic condition where ASRs are “blunted” in
people with conditions ranging from PTSD to MDD to BPD.
The ASR could have a potential use as a functional index of abnormal peripheral immune
functioning; thus, if the ASR is suppressed, it may represent an elevated level of pro-inflam‐
matory or Th1 signaling in the patient. This could be of great importance from a therapeutic
standpoint when one considers the suppressive effects of IL-1 upon sexual motivation in fe‐
male rats are attenuated by indomethacin and ibuprofen [127]. Although blocking prosta‐
glandin synthesis [128] or knocking-out the prostaglandin EP2 receptor does not change
startle reactivity [129], prostaglandin EP1 knock-out mice do exhibit higher startle magni‐
tudes compared to their wild-type control strain [130]. This suggests that EP1 receptors are
in a position to serve as neuroimmune mechanisms to inhibit startle responsivity as well.
Still, beyond the possible pharmacological implications, blunted reactivity to stimuli can
have profound effects on other neural processes as well, and may explain some of the other
symptoms associated with anxiety, MDD, or BPD. For instance, when the same dose of
IL-1β, sufficient to blunt startle responsivity in female SD and Lewis rats, is administered to
female SD rats prior to a simple associative learning procedure the rate of learning is
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slowed. This effect is attributed to a reduction in the neural representation of the uncondi‐
tional reflexive response (i.e. the response is weaker), causing less optimal neural represen‐
tation of the behavioral response to the predictive, conditional stimulus [131]. The
implication is that associative learning may be impaired by either acute or chronic eleva‐
tions in pro-inflammatory or Th1 cytokines. Interestingly, this pattern of effect is not ob‐
served in male rats, at these low to moderate dosages of IL-1β; in fact, these learning
processes are facilitated [132, 133]. Thus, the ASR can serve as a tool to better understand the
blunting of sensory reactivity, but may also have implications for more complex associative
learning processes as well. In Figure 14, we present our theory as to how the ASR may be
changed over time as a function of neuroimmune interactions between peripheral cytokine
signaling (specifically the acute pro-inflammatory response and the downstream Th-1 re‐
sponse) and brain monoamines.
7. Conclusions
The evidence accumulated from these experiments favors a pro-inflammatory mechanism,
over a HPA-axis glucocorticoid mechanism, as the necessary pathway that ultimately leads to
the suppression of startle reactivity following stressor exposure. This finding adds to the ever-
growing evidence that peripheral immune signaling has a significant role in influencing how
the nervous systems functions. In this particular case, we have illustrated how a simple behav‐
ioral reflex can be dampened by pro-inflammatory signals, in the absence of any physical in‐
jury. This shows abnormal levels of peripheral immune signaling could lead to perceived
symptoms reported by patients with PTSD, MDD, or BPD.
Biological differences in how different animals respond to stressor may reflect vulnerability
factors for experiencing different symptoms associated with stress-related disorders, such as
PTSD, MDD, and BPD. Thus, differences observed in the literature concerning startle reactivi‐
ty in female PTSD patients (e.g. [18, 19]) could be due to the types of stressor exposure or indi‐
vidual differences in biological responses. In addition, one cannot rule-out the role of coping
mechanisms. In fact, one could hypothesize that the suppression of startle is an evolutionary
selected response that keeps individuals within a species from continuing to fight a “losing
battle”. If this were the case, then it would be logical for the immune system to play a role in
that trigger-mechanism and not the HPA-axis. The HPA-axis is designed to maintain the fight-
or-flight response [134], which would be in opposition to a behavioral suppression coping re‐
sponse. Others have proposed females are particularly selected to engage in alternative coping
strategies that are in opposition to the fight-or-flight response [135], and one possibility is that
signal reception of the peripheral immune response by the central nervous system is an early
point of diversion in stress coping strategies between males and females. This could provide
inherent propensities to respond differently, but, at the same time, could be modified by expe‐
rience. Such propensities could translate into vulnerability factors for abnormal behaviors
where that response becomes, potentially, maladaptive.
It is well documented that more women experience anxiety disorders and affective disor‐
ders, and there is a significant degree of comorbidity across these disorders – especially as
cases become more severe [136]. There are many potential reasons for the higher rates re‐
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ported in women. For instance, some have recently suggested there is a link between ovari‐
an hormones and the occurrence of specific peptide isoforms that modulate stress
responsiveness and fear conditioning [137]. The data presented here provide another exam‐
ple of how ovarian hormones can influence physiological processes associated with stress
responsiveness. The role of progesterone in this immune model of startle suppression is par‐
ticularly intriguing since progesterone can amplify the pro-inflammatory response through
macrophage migration inhibitory factor [138]. This endocrine influence could, potentially,
cause more Th1 signaling to occur, which, we hypothesize leads to an increase in IL-1β,
causing more Th1 signaling to occur, eventually leading to an increase in IFN-γ release and
subsequent reductions in sensitivity to auditory stimuli. If that same individual has central
nervous system vulnerabilities, such as a particular peptide isoform, then, in addition to an
apparent blunted startle response, the patient may also be exhibiting flashbacks due to en‐
hanced neural processing of fear-associated memory. Thus, female vulnerability for anxiety
and depression symptoms can be seen as a product of multiple mechanisms that modulate
the female physiology and behavior in a manner that, at times, may even be counter to fight-
or-flight, but, nonetheless lead to changes in nervous system functioning, causing the ex‐
pression of a particular set of behavioral symptoms.
There is a growing literature pointing towards a complex interaction between the central nerv‐
ous system and the peripheral immune system that underlies anxiety or affective disorder vul‐
nerability and/or the presence of acute symptoms [139-143]. The utility of being able to use
species-common measures, such as the startle response, has been advantageous to researchers
in aiding them to understand how the brain functions under normal and abnormal conditions.
Here we illustrate how such measures can be applied to the understanding of psychoneuroim‐
mune interaction as they pertain to the influence of the peripheral immune system upon the
brain and behavior. As we gain a greater understanding of the signaling cascades in the pe‐
ripheral immune system, delineating how those signals affect the brain will continue to be im‐
portant for our future understanding of the etiology of mental illnesses.
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